Skip to main content
Year archive

Silence Therapeutics plc — 2021 filings

All 118 regulatory filings released by Silence Therapeutics plc (SLN) in 2021, sourced directly from the official regulator.

118 Filings
2021 Period
2021 filings (118)
Filing Released Lang
6-K
Foreign Filer Report
2021-12-13 English
6-K
Foreign Filer Report
2021-11-26 English
Update on AIM Delisting
Delisting Announcement
2021-11-26 English
6-K
Foreign Filer Report
2021-11-16 English
Third Quarter 2021 Financial Results
Earnings Release 9M 2021
2021-11-16 English
Silence to Present at Jefferies London Conference
Regulatory Filings
2021-11-11 English
Holding(s) in Company
Major Shareholding Notification
2021-11-10 English
New Key Shareholder
Regulatory Filings
2021-11-05 English
6-K
Foreign Filer Report
2021-11-01 English
Result of General Meeting
Declaration of Voting Results & Voting Rights Announcements
2021-11-01 English
Total Voting Rights
Regulatory Filings
2021-11-01 English
Holding(s) in Company
Major Shareholding Notification
2021-10-28 English
Regulatory Filings 2021
Regulatory Filings
2021-10-25 English
424B5
Prospectus
2021-10-22 English
6-K
Foreign Filer Report
2021-10-21 English
Silence Provides Pipeline Updates at 2021 R&D Day
Regulatory Filings
2021-10-21 English
Regulatory Filings 2021
Regulatory Filings
2021-10-21 English
Regulatory Filings 2021
Regulatory Filings
2021-10-21 English
Regulatory Filings 2021
Regulatory Filings
2021-10-20 English
Regulatory Filings 2021
Regulatory Filings
2021-10-20 English
POS AM
Regulatory Filings
2021-10-18 English
POS AM
Regulatory Filings
2021-10-15 English
F-3
Regulatory Filings
2021-10-15 English
6-K/A
Foreign Filer Report
2021-10-15 English
6-K
Foreign Filer Report
2021-10-15 English
Proposed Cancellation of Trading on AIM
Regulatory Filings
2021-10-15 English
Silence and Hansoh Pharma Announce Collaboration
Regulatory Filings
2021-10-15 English
Block Listing Return
Regulatory Filings
2021-10-08 English
Total Voting Rights
Share Issue/Capital Change
2021-10-08 English
Silence Therapeutics to host R&D day
Regulatory Filings
2021-10-07 English
Chardan Genetic Medicines Conference Participation
Regulatory Filings
2021-09-28 English
Holding(s) in Company
Major Shareholding Notification
2021-09-08 English
Holding(s) in Company
Major Shareholding Notification
2021-09-08 English
Silence Appoints Senior VP of BD, AM and NPD.
Board/Management Information
2021-09-01 English
Silence to Participate in Investor Conferences
Regulatory Filings
2021-08-25 English
6-K
Foreign Filer Report
2021-08-12 English
6-K
Foreign Filer Report
2021-08-12 English
Silence Therapeutics Report Half-Year 2021 Results
Earnings Release H1 2021
2021-08-12 English
Holding(s) in Company
Major Shareholding Notification
2021-08-06 English
Holding(s) in Company
Major Shareholding Notification
2021-08-06 English
Total Voting Rights
Regulatory Filings
2021-08-05 English
Notice of half year results
Report Publication Announcement
2021-07-15 English
6-K
Foreign Filer Report
2021-06-15 English
Results of Annual General Meeting
Declaration of Voting Results & Voting Rights Announcements
2021-06-15 English
6-K
Foreign Filer Report
2021-06-07 English
Silence to present SL124 data at EHA
Regulatory Filings
2021-06-07 English
6-K
Foreign Filer Report
2021-05-25 English
$40m Payment from AstraZeneca for Collaboration
Regulatory Filings
2021-05-25 English
6-K
Foreign Filer Report
2021-05-19 English
Phase 1 Study in Healthy Volunteers Positive Data
Regulatory Filings
2021-05-19 English
Silence attends RBC Global Healthcare Conference
Regulatory Filings
2021-05-12 English
6-K
Foreign Filer Report
2021-05-07 English
Notice of AGM
AGM Information
2021-05-07 English
Silence Support International Thalassemia Day
Regulatory Filings
2021-05-04 English
Holding(s) in Company
Major Shareholding Notification
2021-04-30 English
20-F/A
Annual Report FY 2020
2021-04-29 English
Holding(s) in Company
Major Shareholding Notification
2021-04-29 English
6-K
Foreign Filer Report
2021-04-29 English
First patient dosed in GEMINI II
Regulatory Filings
2021-04-29 English
6-K
Foreign Filer Report
2021-04-28 English
Silence Achieves Research Milestone Payment
Regulatory Filings
2021-04-28 English
Grant of Employee Options
Director's Dealing
2021-04-27 English
6-K
Foreign Filer Report
2021-04-19 English
Purchase of ADS and PDMR Shareholding
Director's Dealing
2021-04-19 English
Publication in Cardiovascular Research
Regulatory Filings
2021-04-15 English
424B4
Prospectus
2021-04-12 English
424B4
Prospectus
2021-04-12 English
Regulatory Filings 2021
Regulatory Filings
2021-04-09 English
Regulatory Filings 2021
Regulatory Filings
2021-04-09 English
POS AM
Regulatory Filings
2021-04-08 English
POS AM
Regulatory Filings
2021-04-08 English
Silence to Present at Virtual Needham Conference
Regulatory Filings
2021-04-07 English
20-F
Annual Report FY 2020
2021-03-30 English
Silence Therapeutics Publication of Annual Report
Report Publication Announcement
2021-03-30 English
6-K
Foreign Filer Report
2021-03-30 English
REPLACEMENT Silence Reports Full-year 2020 Results
Earnings Release FY 2020
2021-03-30 English
Silence Reports Full-year 2020 Results
Earnings Release FY 2020
2021-03-30 English
Block Listing Application
Share Issue/Capital Change
2021-03-26 English
424B7
Prospectus
2021-03-15 English
Regulatory Filings 2021
Regulatory Filings
2021-03-15 English
Regulatory Filings 2021
Regulatory Filings
2021-03-11 English
F-1/A
Regulatory Filings
2021-03-11 English
Regulatory Filings 2021
Regulatory Filings
2021-03-10 English
F-1
Regulatory Filings
2021-03-09 English
Silence presents at Barclays Healthcare Conference
Regulatory Filings
2021-03-04 English
Notice of Annual Results
Report Publication Announcement
2021-03-01 English
6-K
Foreign Filer Report
2021-02-26 English
Silence & Mallinckrodt Initiate Work on 3rd Target
Regulatory Filings
2021-02-26 English
Holding(s) in Company
Major Shareholding Notification
2021-02-24 English
Silence to Partake in March Investor Conferences
Regulatory Filings
2021-02-22 English
Regulatory Filings 2021
Regulatory Filings
2021-02-18 English
Silence to present at SVB Leerink Conference
Regulatory Filings
2021-02-18 English
SC 13G
Major Shareholding Notification
2021-02-17 English
SC 13G
Major Shareholding Notification
2021-02-17 English
SC 13G
Major Shareholding Notification
2021-02-17 English
6-K
Foreign Filer Report
2021-02-17 English
First dosing for SLN360
Regulatory Filings
2021-02-17 English
Holding(s) in Company
Major Shareholding Notification
2021-02-15 English
Holding(s) in Company
Major Shareholding Notification
2021-02-15 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-13 English
Holding(s) in Company
Major Shareholding Notification
2021-02-12 English
Holding(s) in Company
Major Shareholding Notification
2021-02-12 English
Additional Listing and Total Voting Rights
Share Issue/Capital Change
2021-02-12 English
Holding(s) in Company
Major Shareholding Notification
2021-02-11 English
Holding(s) in Company
Major Shareholding Notification
2021-02-11 English
Additional listing and Total Voting Rights
Share Issue/Capital Change
2021-02-08 English
6-K
Foreign Filer Report
2021-02-06 English
Silence Announces $45m Private Placement
Capital/Financing Update
2021-02-05 English
Additional listing and Total Voting Rights
Share Issue/Capital Change
2021-01-29 English
Additional listing and Total Voting Rights
Share Issue/Capital Change
2021-01-25 English
Holdings in Company
Major Shareholding Notification
2021-01-07 English
6-K
Foreign Filer Report
2021-01-06 English
Grant of Options
Director's Dealing
2021-01-06 English
Holding(s) in Company
Major Shareholding Notification
2021-01-06 English
Board of Directors Appointment
Board/Management Information
2021-01-06 English
Silence Therapeutics Appoints Craig Tooman as CFO
Board/Management Information
2021-01-06 English
January Conference Schedule
Regulatory Filings
2021-01-05 English
Holdings in Company
Major Shareholding Notification
2021-01-04 English